Click on the image to see our upcoming schedule of Life Science events.
FountainBlue's Life Science Entrepreneurs' Forum
Join the life science list by selecting the image on the left, or join multiple lists by completing the form on the right.
Groups include: clean energy, high tech, life science, virtual worlds, women leaders, and executives.
FountainBlue's Life Science Entrepreneurs' Forum
Topic: Emerging
Trends in Medical Devices - Mobile Health, Personalized Medicine and Consumerization
Date & Time: Monday,
September 27 from 5:30 - 7:30 p.m.
Location: UCSC Extension, 2505 Augustine Drive, Santa
Clara
Pre-register: $21
members, $32 partners, $42 general
Late and On-Site: $42 members, $52 non-members, $124
Ongoing membership and admission
Registration: Please
pre-register by noon on 9/24 using the adjacent PayPal link
Audience: Life Science entrepreneurs, intrapreneurs and
investors, no service providers please
Emerging Trends in
Medical Devices - Mobile Health, Personalized Medicine and Consumerization
Our annual state of the medical device industry event
will focus on some of the hottest areas in medical devices today: from mobile
health solutions to personalized medicine and consumer devices. Come hear about
these hot new trends, and see how start-ups are leading medical device
innovations around mobile health and personalized medicine, bringing devices
into the hands of consumers.
Facilitator
Geetha Rao, PhD, Springborne Life Sciences
Panelist
Anne DeGheest, Managing Director and Founder, HealthTech Capital, Managing
Partner and Founder
MedStars
Panelist
Dave Scott, Director, Imaging Systems, Intuitive Surgical, Inc
Panelist
Clarence Wilhelm, LifeScan, to be confirmed
Other
Panelists to be confirmed
Presenting
Entrepreneur Marc Bandt, CEO, Pelesend
Presenting
Entrepreneur: Personalized Medicine
Presenting
Entrepreneur: Diagnostic for Consumers
NO SERVICE PROVIDERS
PLEASE.
Pre-register for our upcoming FountainBlue life science event. Note that registrations must be time-stamped by noon on the business day prior to the event, generally Fridays for events to be held on Mondays.
As a member, you are welcome to pre-register for any other upcoming FountainBlue event as well. Note that registrations must be time-stamped by noon on the business day prior to the event. Registrations arriving after that deadline will be applied to NEXT MONTH's event.
Panelist Bios
Facilitator Geetha Rao,
PhD, CEO, MyMedFax and Springborne Life Sciences, VP Strategy and Risk Management, Triple Ring Technology
Dr. Geetha Rao has over 20 years of experience in high-risk technologies
includes being an entrepreneur, executive and strategic advisor to numerous
early-stage life sciences ventures. She is the founding CEO of Springborne Life
Sciences, providing advisory services and interim management to medical device,
biotechnology and other life-sciences enterprises with a focus on emerging
business challenges and operational excellence that meets best-in-class,
international standards. She serves as Vice President of Strategy and Risk
Management at Triple Ring Technologies, a medical device incubator and contract
development firm. She is an internationally recognized expert in risk
management and liability and has served on several international policy making
bodies, and as an invited expert to regulatory agencies, including the FDA.
Geetha chairs the MIT/Stanford Venture Lab's Emerging Business Track
for Life Sciences, serves on the Life Sciences Committee for Astia, the leading
organization supporting women-founded and women-led start-ups, and has been a
guest faculty on Stanford University's Biodesign Innovation Program. She is a
graduate of the Indian Institute of Technology, Madras, holds a doctorate from
MIT and a masters degree from Stanford University's Graduate School of Business,
where she was a Sloan Fellow.
Panelist Anne
DeGheest, Managing Director and Founder, HealthTech Capital and Managing
Partner and Founder, MedStars
Anne has 25 years
investing experience with MedStars, and has been a pioneer investor in the
field of HealthTech. Companies in which Anne has invested have raised over $500
million in venture capital and grew to $6 billion market cap.
Anne has been a
mentor capitalist specializing in investing and mentoring early-stage start-ups
in healthcare companies including Pyxis
(CareFusion), Aspect Medical
(acquired by Covidien), VISX
(acquired by AMO), Thermage
(merged into Solta Medical), VISICU(acquired
by Philips), Masimo
(Nasdaq: MASI). She also helped grow new entrepreneurial division of large
corporations like Johnson & Johnson, Baxter, Medtronic and McKesson. She
was also part of the founding executive team of Nellcor (a division
of Covidien), MedPool and OmniCell
(Nasdaq: OMCL). Anne earned an MS, Brussels and an MBA, Harvard.
Panelist Dave Scott,
Director, Imaging Systems, Intuitive Surgical
Dave Scott is the
Senior Product Manager for Vision and Medical Imaging at Intuitive
Surgical. He has spent the last 15 years in research and development
related to medical imaging and diagnostics. Dave spent several years
developing novel medical imaging solutions for the Medical Technology Program
and Center for Advanced Signal and Imaging Sciences at Lawrence Livermore
National Lab. At LLNL he worked on next generation breast cancer
screening systems utilizing ultrasound tomography and acoustic scanning systems
for prosthetic heart valve assessment. He was part of the core start-up
team at Xradia, Inc where he was awarded an R&D100 award for the
development of the Nano-XCT, a 50nm resolution x-ray tomography system.
He is a co-founder of Varioscale, Inc, a start-up venture dedicated to bringing
ultra-high resolution laser etching technology to the semiconductor and life
science communities for "lab-on-a-chip" applications.
Currently, Dave is
dedicated to identifying advanced imaging technologies for the daVinci Robotic
surgical platform through the development of technology partnerships and internal
research efforts. His experience in medical device R&D along with his
startup experiences allow him to provide invaluable feedback and guidance for
early stage ventures. He regularly works with start-up companies
developing strategies for technology development and product positioning for
acquisition or licensing. Dave holds a BS in Aerospace engineering from
the University of Kansas and an MS in Aerospace/Medical Engineering from the
University of Colorado, Boulder.
Presenting Entrepreneur Marc Bandt, CEO, Pelesend Inc.
Marc has raised initial and follow-up funding for initial product
development on several occasions. His run rate for current start-up over the
next 12 months is to exceed $500,000 with cash-flow break-even achieved within
the first 18 months of founding. Marc specializes in the use of high technology
in health care although considered an experienced silicon valley generalist
when it comes to marketing, product development, and technology use. He applies
extensive experience in launching, developing and maturing software and
hardware companies with an emphasis on the use of the latest "tools"
in health care and it's associated organizations.
Marc has raised money, written and executed business plans, established and
supported the corporate message to customers, potential investors and business
partners, identified suitable technologies and directed their use against
business goals. He earned his BS from Southern Methodist University and his MBA
from Cox School of Business MBA.
FountainBlue stimulates collaborative innovation, one
conversation, one leader, one organization at a time through our monthly
events, our dynamic communities, our ongoing discussions on entrepreneurial
issues, our invitation-only CEO forums, and through our consulting services.
FountainBlues
Life Science Entrepreneurs Forums were launched in September 2006 and have
continued to grow and become an exceptionally high value entrepreneur event in
Silicon Valley. These events routinely attract between 40 to more than 100 life
science entrepreneurs, intrapreneurs and investors each month. The topics cover
the range of early stage entrepreneurship challenges and opportunities. An
invitation to this months event is below, along with a calendar of past and
upcoming topics and speakers, and notes from all our previous sessions are
available at http://fountainblue.biz/cleanenergy/cleanenergynotes.html.
Our
events are typically held on the third Mondays of the month (or fourth Mondays
in January and February) from 5:30 until 7:30 p.m., and include networking and
registration for the first half hour, fast pitches from three entrepreneurs to
start off the event, and a panel discussion, with half an hour reserved at the
end for Q&A. Testimonials are available below as well. If you are an
entrepreneur, intrapreneur or investor, we invite you to sign up for our free
mailing list using the form above. We hope to see you at an event soon. (Please
note that this event is not for service providers.)
We welcome your continued participation and input and hope to
connect with you soon.
Join our community on BigTent by visiting https://www.bigtent.com/groups/fountainblue See the list of upcoming events for the month and register to
attend one soon! Sign up for our free newsletter by completing the form above If you are an early stage entrepreneur and would like to discuss
your new venture, suggest some office hours on Mondays, Wednesdays or Fridays
between 8:30 a.m. and 1:00 p.m. Peruse our web site to find out more about FountainBlue and all
our activities
Send us an e-mail to tell us how we can best serve you! info@svlifescience.com
We would like to thank and acknowledge our 2010 Life Science sponsors. Our work is not possible without their support, and we encourage you to consider their services.
KPMG
Below is our
calendar for our 2010 life science entrepreneurs' forums for your
planning purposes. Please note that you may register only for the next
upcoming event. We invite your participation as part of the program
committee and we invite your nominations for entrepreneurs,
intrapreneurs or investors to join our panels. Service providers interested in sponsorship opportunities should contact us at info@svlifescience.com and suggest a good time to talk prior to the next meeting.
Monday,
January 25 at KPMG 500 E. Middlefield Road in
Mountain View
Life Science Angel Investor's Panel: Trends for 2010
Sponsored
KPMG
Facilitator Conor Moore,
Partner, KPMG
Panelist Anne DeGheest,
Founder and Managing Director, MedStars, Strategic Advisor at PolyRemedy, Inc
Panelist Stuart Eckmann,
Keiretsu Forum and Life Science Angels
Panelist Don Ross,
Member, Life Science Angels and Sand Hill Angels
Panelist Michael
Weickert, President and CEO, S.E.A. Medical Systems, Inc., Member, Life
Science Angels, Venture Partner, Kranenburg Fund
Life
science angel investors are generally seasoned executives with deep strategic
and operational experience in running successful life science businesses,
from concept to clinical trials to regulatory approvals, manufacturing and
distribution. They generally also have extensive experience within
corporations in various roles, and continue to develop these partnerships as
they support their portfolio companies.
The
life science angel investors panelists have been seen a wide range of life
science business models, and have their own thoughts and recommendations on
how to be successful in these challenging times. Topics will include how
early stage companies can position themselves for successful partnerships and
fundings, strategically plan your business based on evolving market needs,
tightly manage cash flow, and build strategic alliances with larger
organizations, angels, research organizations, and other key stakeholders.
As part
of our program this month, we will solicit feedback from all our attendees on
the challenges and opportunities in through facilitated small groups, based
on life science sub-industry topics: Software solutions for the healthcare
industry, medical devices, personalized medicine, medical imaging, and
biopharma.
Monday,
February 22 @ Bay Cafι Clubhouse, 1875 Embarcadero, Palo Alto
Show Me
the Money: Resourceful Ways to Secure Funding for YOUR Life Science Company
in THIS Economy
Sponsored
by KPMG
Facilitator
Maria Walker, Senior Director, KPMG
Panelist
Zachary Antovich, President and CEO, Linkage Biosciences Inc
Panelist
Howard Edelman, President & CEO, VitalWear
Panelist
Oostur Raza, President and CEO, OmegaGenesis
Show Me
the Money: Resourceful Ways to Secure Funding for YOUR Life Science Company
in THIS Economy
Even if
the economic projections are getting more rosy, ask anyone running an early
stage company and they will tell you that times are tough out there! The life
science industry has provided a ray of hope when the economy was at its
darkest.
Historically
known as a slow-moving industry, it has also been more resilient and less
impacted by the recent economic challenges. This month, we will feature a
panel of seasoned entrepreneurs and investors who will share their thoughts
and suggestions on how to secure funding for life science start-ups, from
grant and government funding to angel, venture and corporate funding. They
will share their recent success stories and help you brainstorm how to best
position your company financing.
International
Challenges and Opportunities for Life Science Companies
Sponsored by Morrison Foerster and KPMG
Facilitator
John Bashkin, VP of Strategic Business Development, Triple Ring Technologies
Panelist
William Goure, President and Chief Executive Officer, Acumen Pharmaceuticals
Panelist
Evgeny Zaytsev, General Partner, Helix Ventures
Panelist
Key Shin, Of Counsel, Morrison Foerster LLP
Resilient,
resourceful, life science entrepreneurs are advancing their businesses, and
developing international programs and relationships to better advance their
technology, provide clinical research, and serve their markets. For this
panel, life science entrepreneurs, intrapreneurs and investors on whats
working and whats not in different international markets.
Monday,
April 19 @ Bay Cafι Clubhouse, Palo Alto
Physician's Panel: Partnering with Entrepreneurs to Better Address
Patient Needs
Sponsored
by KPMG and Royse Law Group
Facilitator
Roger Royse, Rose Law Group
Panelist
D. Christopher Chung, M.D., Vice President, Medical Affairs, R&D, and
Engineering, Natus Medical
Panelist
Dr. Arthur Douville, MD, Chair, Advisory Board, Clinsensus, Chair of the
Department of Neurology at Good Samaritan Hospital in San Jose
Panelist
Gary Heit, former Stanford Professor, Staff Neurosurgeon, Dept of
Neurosurgery, Kaiser Permanente Hospital, Redwood City
Panelist
Michael Leong M.D., Interim Executive Director, Pain Center Stanford
Panelist
Brian Wilfley, Chief Scientist and co-Founder, Triple Ring Technologies
Physicians
are feeling the pressures of the changing policies, economies and technologies,
which is influencing how they run their practices, and how they work with
their patients. Our panel this month will feature physicians who are
partnering with entrepreneurs, intrapreneurs and investors and proactively
facing these changes, and a set of entrepreneurs who are developing solutions
to support physicians in addressing these issues.
Monday,
May 17 @ Bowne, Palo Alto
Technology
Acceleration, Globalization Pressures and the Future of Pharma
Sponsored
by KPMG and Royse Law Group
Facilitator
Laurie Allen, Attorney and Director of Southern California Practice, Royse
Law Group Inc.
Panelist
Andrei Blasko, Director of Analytical Method Development, Pain Therapeutics
Panelist
Bill Goure, President and CEO, Acumen Pharmaceuticals
Panelist
David Lustig, VP of Business Development, Optivia Biotechnology Inc.
Pharma
companies large and small are faced with the rapid pace of technology
development, both in the labs and in devices and software, and the rapid
acceleration of globalization factors leading to outsourcing and larger
international markets, and other policy and regulatory challenges inherent to
the industry overall. Our seasoned panel of experts will month will share
innovations in technology development, in collaborations, in business strategies,
and other strategies adapted to keep up with the times.
Monday,
June 14 @ UCSC Extension, Santa Clara
Trends and Opportunities for Medical Imaging
Sponsored by KPMG
Sponsor
Mark Foster, General Counsel and Secretary, Volumetrics Medical Imaging
Panelist
Tobias Funk, PhD, Principal Physicist, Triple Ring Technologies
Panelist
Dave Scott, Director, Imaging Systems, Intuitive Surgical
Presenting
Entrepreneur Mark Foster, General Counsel, Volumetrics
Presenting
Entrepreneur James Peacock, Founder; CEO; Managing Member (Chairman), NociMed
Medical
imaging solutions are showing great promise in meeting the therapeutic and
diagnostic needs of patients. This month, our panel will focus on successful
medical imaging solutions and raise discussions about the near and long term
potential for the medical imaging industry.
Panelist
Brent Blackburn, President and CEO, Rpaidscan Pharma Solutions, Inc,
Panelist
Dave Lustig, VP of Business Development, Optivia Biotechnology Inc.
Panelist
Melanie Sit, Business Strategist, Optovue
Panelist
Alice Varga, VP of Regulatory Affairs and Quality Systems, Geron
Navigating
the FDA approval processes takes a great idea, exceptional technology,
stellar connections, not to mention patience, fortitude, and no small amount
of luck.
This
month, we will share strategies on how to get your drugs or devices approved
by the FDA, and share how we can collaboratively build a balance between
efficacy, efficiency and effectiveness for patients, physicians and providers
from hospitals to insurance companies to entrepreneurs and intrapreneurs.
Monday,
September 27 @ Altera 101 Innovation Drive in San Jose
Emerging Trends in Medical Devices Mobile Health, Personalized
Medicine and Consumerization
Facilitator Geetha Rao, PhD, Springborne Life Sciences
Panelist VC to be confirmed
Panelist from Intel to be confirmed
Panelist from Altera to be confirmed
Panelist from LifeScan to be confirmed
Presenting Entrepreneur: Mobile Health
Presenting Entrepreneur: Personalized Medicine
Presenting Entrepreneur: Diagnostic for Consumers
Our annual state of the medical device industry event will focus on
some of the hottest areas in medical devices today: from mobile health
solutions to personalized medicine and consumer devices. Come hear about
these hot new trends, and see how start-ups are leading medical device
innovations around mobile health and personalized medicine, bringing devices
into the hands of consumers.
Monday,
October 18 @ location tbd
Software Meets Healthcare
Sponsor Facilitator to be confirmed
Panelist VC to be confirmed
Panelist from Intuitive Surgical to be confirmed
Panelist from Altera to be confirmed
Panelist from Affymetrix to be confirmed
Panelist
from Applied Biosystems, a Life Technologies Company, to be confirmed
Presenting Entrepreneurs to be confirmed
This
month we examine the convergence of technology and health care, and profile
software solutions which benefit health service professionals, from health IT
platforms to pharmaceutical tracking, health monitoring and more.
Monday,
November 15 at Life Technologies, 850 Lincoln Centre Drive in Foster City
Personalized Medicine, Biomarkers, Invitro Diagnostics: The Science
Advances, The Business Opportunities, The Cultural Dilemmas
Facilitator
tbd
Panelist from Applied Biosystems, part of Life Technologies, to be confirmed
Panelist VC, tbd
Panelist from Stanford, tbd
Panelist Brandon Steele, Vice President, Commercial Operations, IncellDx,
Inc.
Presenting Entrepreneur tbd
Presenting Entrepreneur tbd
Presenting Entrepreneur tbd
The
accelerated pace of technology advancements is opening up new offerings in
personalized medicine, in biomarker training, in Invitro diagnostics. This
month we feature groundbreaking leaders to showcase advances and opportunities
in this market and touch upon cultural and moral dilemmas which arise as
these offerings gain traction.
Monday,
December 20
Holiday Break
n/a
Please join us in thanking our facilitators, speakers, and sponsors for FountainBlue's 2009 life science events.
Angel Panelists:
o Stuart Eckmann, Keiretsu Forum and Life Science Angels (Bio and Device
Committees)
o Elaine Heron, Life Science Angels and LabCyte
o Anne DeGheest, MedStars
o Don Ross, Life Science Angels and Sand Hill Angels
Featured Recently-Funded Entrepreneurs:
o Mitchell Mutz, CSO, Amplyx Pharmaceuticals
o Michelle Stecklein Call, CEO, Lypro BioScience
Life
science angel investors are generally seasoned executives with deep strategic
and operational experience in running successful life science businesses,
from concept to clinical trials to regulatory approvals, manufacturing and
distribution. They generally also have extensive experience within
corporations in various roles, and continue to develop these partnerships as
they support their portfolio companies.
The life science angel investors weve recruited for this months panel have
been seen a wide range of life science business models, and have their own
thoughts and recommendations on how to be successful in these challenging
times. Topics will include how early stage companies can:
- position themselves for successful partnerships and fundings,
- strategically plan your business based on evolving market needs,
- tightly manage cash flow, and
- build strategic alliances with larger organizations, angels, research
organizations, and other key stakeholders
Facilitator Steven Cui, Of Counsel, Jones Day
Panelist Bonnie Anderson, CEO, Veracyte, Inc.
Panelist Deborah Kilpatrick, Vice President, Market Development, CardioDx,
Inc.
Panelist Geetha Rao, Springborne and Molecular Image
Panelist Mike Richey, Chief Business Officer, Tethys Bioscience
Panelist David Rollo, President, Cell Point LLC
With
advancements in technology and science, we have not only a greater
understanding of people and their various diseases, but we are also better
understanding the human genome, and are making progress in creating
personalized medicines to customize treatment and even preventive care for
people.
But these advancements are also raising questions: what's the myth, and
what's the science? What's in the research, blue-sky phase, and who is
providing what REAL solutions now? And where's the money in it? What does it
mean for the average person? Our panel will facilitate a discussion covering
these topics and more.
Facilitator John Bashkin, Triple Ring Technologies
Panelist Rob Abrams, Operating Partner, Sanderling Ventures, Former Head of
Business Development, Boston Scientific
Panelist Dave Scott, Senior Product Manager, Vision Systems, Intuitive
Surgical
Panelist Niamh Pellegrini, General Manager, LifeScan, a J&J Company
In a
down market, everyone conserves cash, and plans for the future. Experienced
executives and entrepreneurs find resourceful ways to continue their R&D,
especially during a downturn when there are so many cost-effective resources
and opportunities for new products and markets with the return to economic
stability. This month, we will convene corporate intrapreneurs who share
their R&D strategies, and their thoughts on which markets will be hot.
Facilitator Myriam Curet, MD, Stanford University, Chief Medical Advisor,
Intuitive Surgical
Panelist Shahram S. Gholami, M.D., Urological Surgeon
Panelist Gary Heit, PhD, MD, former Assistant Professor, Director of
Functional Neurosurgery, Dept of Neurosurgery, Kasier Redwood City
Panelist Frank Lai, MD, Department of Urology, El Camino Hospital
Panelist Michael Leong, MD, Anesthesiologist
Panelist James Lilja, PhD, OBGYN
In a
down market, everyone conserves cash, and plans for the future. Experienced
executives and entrepreneurs find resourceful ways to continue their R&D,
especially during a downturn when there are so many cost-effective resources
and opportunities for new products and markets with the return to economic
stability. This month, we will convene corporate intrapreneurs who share their
R&D strategies, and their thoughts on which markets will be hot.
Facilitator Joyce Chiarenza, Chiarenza Consulting, L.L.C., Certified Clinical
Compliance Professional, and Instructor, UCSC Extension
Panelist Walt Cecka, Senior Director, Program Management, Triple Ring
Technologies
Panelist Krishna Ghosh, VP of Quality and Compliance, Arbor Vita
Corporation
Panelist Jacques Ginestet, Director, Sustaining Engineering, LifeScan
Panelist Chris Panarties, Sr. Director, Reimbursement, Health Economics and
Pricing, NeurogesX
Panelist Susan Rowinski, Sue Rowinski Group LLC, Reimbursement &
Marketing Consulting
Success
in today's life science regulatory environment requires balancing the
management and impact of federal, state and local policies on the rapid pace
of technology development and science advancement in today's life science businesses.
This month's seasoned life science specialists will share their perspectives
on the impact and interplay of regulatory requirements on reimbursement,
technology development, science exploration and other business functions for
life science entrepreneurs, intrapreneurs and investors.
Facilitator Dick Haiduck
Panelist Rich Ferrari, Partner, De Novo Ventures
Panelist Stevan Jovanovich, CEO, Microchip Biotech
Panelist Yvonne Linney, VP, Strategy, Marketing and Business Development,
Life Sciences Solutions Unit, Agilent
Panelist Glen Sato, Partner Cooley Godward Kronish, LLC
Panelist Charles Versaggi, CEO, OsteoCorp
Presenting Entrepreneur: Richard Lotti, CEO, Quadra Vascular
Presenting Entrepreneur: Dr. Sampath Srikanth, DermDx's CEO
Presenting Entrepreneur: Roger Thomas, CEO, Topavance
Even
when times were flush, it was difficult for life science entrepreneurs and
execs to develop a comprehensive strategy that could be well executed. The
additional challenges of regulatory, clinical trials, manufacturing,
distribution, etc., add to the normal business challenges of people,
technology and markets. Yet, no matter what the circumstances, resourceful
entrepreneurs, intrapreneurs and investors find a way to make it work. This
month's panel will share the creative strategies that are working for them,
and the additional work they need to do to navigate today's challenging
business environment.
Facilitator Peter Berger II, CEO, Alitora
Panelist Ian Irwin, Director of Drug Discovery, Parkinsons Institute
Panelist Michael ODonnell, Partner, Wilson Sonsini
Panelist Ted Spack, Managing Director, Fast Forward LLC
Panelist Craig Taylor, Co-Founder and General Partner, Alloy Ventures
Presenting Entrepreneur: Yadon Arad, Tiara Pharmaceuticals
Presenting Entrepreneur: Julia OConnor, CEO, Accelalox Inc.
Presenting Entrepreneur: David Zarling, CEO, Colby Pharmaceuticals
Life
science professionals are faced with the usual challenges in developing,
testing, manufacturing, approving and distributing biopharma solutions from
drug discovery to therapeutics to enabling platforms. These unique challenges
extend the time from inception to market, yet the companies that successfully
navigate these challenges are companies to watch bringing financial returns
to companies, and products and services to markets.
With the dramatic and rapid changes in policy and administration and outlook
toward the life science industry overall, new interest has been placed on how
to identify the key players in the biopharma market, and facilitate forward
progress for people and organizations in this industry. This months panel
will address todays unique challenges and share successes worth noting.
Facilitator Geetha Rao, Springborne Life Sciences
Panelist Joseph Heanue PhD, President, Triple Ring Technologies
Panelist Frank Ingle, Senior Research Fellow, Electrophysiology Division,
Boston Scientific
Panelist Sharbel Noujaim, VP of Product Engineering, LifeScan
Presenting Evelyn Hu, Chief Marketing Officer and Director of Product
Development, iShoe
Presenting Tom Moore, President and CEO, Silicon Valley Medical Instruments
Presenting Michael Weickert, President and CEO at SEA Medical Systems, Inc
Medical
Device Advances: From Implantables to Surgical Tools, From Diagnostics to
Therapeutics
This month we will highlight successful medical device solutions from
implantables to clinical equipment and also cover partnering across academia
and industry to advance the industry, and the future of medical device
industry in general.
Monday,
October 19 @ Intuitive Surgical
Software
Meets Healthcare Services: Health IT Platforms, Pharmaceutical Tracking,
Remote Monitoring and Beyond
Facilitator Russell Singleton, President and CEO, Molecular Image
Panelist Shannon Kelley, Director of Marketing, Intuitive Surgical
Panelist John Steuart, Claremont Ventures
Panelist Evgeny Zaytsev, Helix Ventures
Panelist Steve Douglas, CEO, Data Physics Research
Presenting Entrepreneur Rohan G.F. Coelho, CEO, Rexanto
Presenting Entrepreneur Anthony Gioeli, CEO, MedAttune
This
month we examine the convergence of technology and health care, and profile
software solutions which benefit health service professionals, from health IT
platforms to pharmaceutical tracking, health monitoring and more.
Facilitator Linda K. Molnar, LKM Strategic Consulting
Panelist Doug Dolginow, PhD, BOD, Advisor, Founder CSO/CMO, Veracyte, Inc,
and CEO and BOD, NanoValent
Panelist Kimberlee Caple, Vice President, Genetic Systems Division, Applied
Biosystems, part of Life Technologies Corporation
Panelist Ted Driscoll, Venture Partner, Claremont Ventures; Active Member,
Life Science Angels; Founding Director, Sand Hill Angels
Panelist Kendall Wu, Product Manager, Cytogenetics Portfolio, Affymetrix
Presenting Entrepreneur Richard A. Goozh, Sr. VP, Strategy & Finance,
Wave 80 Biosciences; Managing Director, Cambrian Partners
Presenting Entrepreneur Dick Haiduck, Partner to the CEO, Implicit
Bioscience and Compugen, advisor to the Queensland Australia government
Presenting Entrepreneur Massimo Bocchi, Chief Technology Officer, MindSeeds
Laboratories s.r.l. and Fulbright scholar
The
accelerated pace of technology advancements is opening up new offerings in
personalized medicine, in biomarker training, in Invitro diagnostics. This
month we feature groundbreaking leaders to showcase advances and
opportunities in this market and touch upon cultural and moral dilemmas which
arise as these offerings gain traction.
Monday,
December 21
Holiday
Break
n/a
Below is a calendar for our 2008 life science entrepreneurs' forums, to take place in the evenings from 5:30 - 7:30 p.m.
Date
Title
Facilitator and Panelists
Tuesday, January 22
Life Science Angels Panel: Investment Trends in 08
Facilitator Aliki Helman, serial entrepreneur and former corporate exec
Panelist Stuart Eckmann, Keiretsu Forum and Life Science Angels (Bio and Device Committees)
Panelist Elaine Heron, Life Science Angels and LabCyte
Panelist Bob Molinari, MedStars
Panelist Don Ross, Life Science Angels and Sand Hill Angels
Tuesday, February 19
Incubating Life Science Companies
Facilitator Ted Spack, SRI International
Panelist Gayle Fagan, Managing Director, San Jose Biocenter
Panelist Jim Rurka, co-founder of Blanca Pharmaceuticals
Panelist Dave Yeomans, Trigemina Inc.
Monday, March 17
Partnering with Life Science Corporations
Facilitator Bruce W. Jenett, Partner, DLA Piper
Panelist Rob Abrams, Vice President New Business Development / New Ventures, Boston Scientific
Panelist Martin Doyle, Director of Mergers and Acquisitions, Applied Biosystems
Panelist Graeme R Martin Ph.D., Takeda Research Investment Inc
Panelist Ali Nasser, Director of Business Development, Roche Molecular Systems
Monday, April 21
Trends in Pharma
Facilitator Ted Spack, Senior Director of Business Development, SRI International
Panelist Dick Haiduck, Partner to the CEO of Implicit Bioscience and Cytopia
Panelist David Summa, CEO, Acumen Pharmaceuticals
Panelist Dr. Nicholas Saccomano, Senior Vice President of Worldwide Exploratory Science and Technology, Pfizer
Monday, May 19
Trends in the Medical Device Development
Facilitator Bruce W. Jenett, Partner, Co-Chair, Global Life Sciences Sector, DLA Piper US LLP
Rob Abrams, Operating Partner, Sanderling Ventures; former Vice President New Business Development/ New Ventures, Boston Scientific Corporation
Richard M. Ferrari, Managing Director, De Novo Ventures
William T. Harrington, MD, Partner, Three Arch Partners
Geetha Rao, Serial Medical Device Entrepreneur and Executive, Springborne Life Sciences and Triple Ring Technologies
Monday, June 16
Holiday Break
n/a
Monday, July 21
Holiday Break
n/a
Monday, August 18
Issues in Collaborative Development
Facilitator/moderator: Alan Schwartz-Ocio, Of Counsel, DLA Piper LLP Panelists: Adam Bristol, Investor, Biotechnology Value Fund
Jeff Jonker, Director of Business Development, Genentech
Jim I McLoughlin, Executive Director, Worldwide Business Development & Pfizer Venture Capital; Pfizer Inc. - Biotherapeutics and Bioinnovations Center
John Wulf, EVP & CBO, Trellis Bioscience
Monday, September 15
From Strategy to Execution: Growing Your Company to the Next Level
Facilitator Russell M. Singleton, Ph.D., President and CEO, Molecular Image, Inc.
Robert Abrams, Operating Partner, Sanderling Ventures
Bill Goure, Ph.D., COO, Acumen Pharmaceuticals
David Horwitz, M.D., Ph.D., World Wide Vice-President of Clinical Affairs and Evidence-Based Medicine, LifeScan
Ed Torres, Managing Director, Lilly Ventures
Monday, October 20
Show Me the Money: from Angels to Grants to VCs
Facilitator Geetha Rao, Springborne Life Sciences and Triple Ring Technologies
Panelist Adam S. Bristol, Ph.D., Biotechnology Value Fund, L.P.
Panelist Gino Di Sciullo, Ph.D., Charter Life Sciences
Panelist Dr. Evgeny Zaytsev, Partner, Asset Management Company
Panelist Allan W. May, Life Science Angels
Panelist Tom Rodgers, Principal, Advanced Technology Ventures
Monday, November 17
International Partnerships for Life Science Execs
Facilitator Simon Taylor, President, ACN Securities
Panelist Rinko Ghosh, Senior VP of Business Development and Alliance Management, Nektar Therapeutics
Panelist Phyllis Whiteley, PhD, Executive in Residence, Mohr Davidow Ventures
Panelist David Zarling, CEO, Colby Pharmaceutical Company
Other Panelists to be confirmed
Monday, December 15
Holiday Break
n/a
We are grateful to our partners and speakers for our 2007 programs and proudly acknowledge them below.
Date
Title
Facilitator
Tuesday, February 20
Corporate Investments in Life Science Companies
Facilitator Geetha Rao Panelist Linda Greub, Business Development, Applied Biosystems Panelist Eran Raber, Director, New Business and Venture Investments, Agilent Technologies Panelist Simon Greenwood, Ph.D., Senior Manager, Business Development, Genentech, Inc.
Monday, March 19
Positioning Your Life Science Company for Outside Funding
Facilitator Geetha Rao Panelist Brian Boyer, Perkins Coie LLP Panelist John Cornwell Life Science Angel Panelist Ken Martin, Onset Ventures Panelist David Miller Founder, InnoSpine
Monday, April 16
R&D Funding Opportunities
Facilitator Brian Boyer, Perkins Coie LLP Panelist Jeff Fairman, founder and senior research director, Juvaris Panelist Tom Gutshall, Founder and Former CEO, Current Chairman of Cepheid Panelist David Light, Business Builders
Tuesday, May 22
Trends in Life Science Investing
Facilitator Roy Fiebiger, Sanford Rose and Associates Panelist Andrew Farquharson, InCube Ventures Panelist Nina Kjellson, Partner, InterWest Partners Panelist John Maroney, General Partner, Delphi Ventures Panelist Kevin Wasserstein, Versant Ventures
Monday, June 18
Successful Entrepreneur Panel
Facilitator Roy Fiebiger, Sanford Rose and Associates Panelist Brent Contstantz, Skeletal Kinetics LLC Panelist Charlie Wen, Current founder and CTO, Tensegrity, former CEO of OrthoClear, Karegiver, former director of engineering and Align Technology Panelist Tony Zhang, PhD President, CEO and Chairman Formurex
Monday, July 16
Your Company's Value Proposition
Facilitator Sharon Lewis, President, Strategic Impact, Inc. Panelist Valli Bindana, President & Creative Director, KreativeVistas Panelist Ruth Cavagnaro, CEO, ChorusWare (Astia Portfolio Company) Panelist Chisato Ishii, Investment Partner, JAIC America, Inc. Panelist Ken Macrae, PhD, MD, EVP and Serial CEO Panelist John Reed, Global Operations, Agilent Technologies Panelist - Fred Seddiqui, CEO, Avantis Medical Systems, Inc.
Monday, August 20
Outsourcing Options for Life Science Companies
Co-Facilitator Simon Goldbard, Ph.D., Corex Co-Facilitator Matt Perez, NearSoft Panelist Oren Beske, Ph.D., Director, Aragen Bioscience, Inc. Panelist Simon Greenwood, Senior Manager, Business Development, Genentech, Inc. Panelist Alshad S. Lalani, Ph.D., Director, Preclinical & Translational Oncology, Novacea, Inc. Panelist Angie You, COO Ren Pharmaceuticals
Monday, September 17
Navigating Government Regulations
Facilitators Linda Judge and Alan Schwartz Ocio from DLA Piper Panelist Anar Kotadia, MSS Consulting and Chair San Francisco Bay Area Chapter, Regulatory Affairs Professionals Society, formerly with Abbott, (with medical device perspective), RAPS Panelist Alan Jacobs, Acorn Biomedical (early stage clinical development) Panelist Geetha Rao (with a medical device perspective ) Panelist Rick Srigley, CEO & President of Aragen Bioscience
Monday, October 15
Marketing and Sales Operations for Life Science Entrepreneurs
Facilitator, Sharon Lewis, Founder and President, Strategic Impact, Inc. Panelist, Neelam Vaidya, Co-Founder and CEO, ChiroSolve Panelist, Rajiv Mehta, Co-Founder and CEO, Zume Life Panelist, Martin Babler, Entrepreneur, former VP Sales and Marketing Immunology, Genentech Inc. Panelist, Michael Mitchell, VP Marketing, Cantimer Panelist, Dan Galles, General Partner, HLM Venture Partners
Monday, November 19
Building An A+ Life Science Management Team
Facilitator Roy Fiebiger, Managing Partner, Sanford Rose Associates Panelist Chuck Brynelsen, CEO of IntraPace Panelist Dan Galles, General Partner, HLM Venture Partners Panelist Jonathan Goldman, MD., CMO Panelist Zack Scott, Director, Burrill & Company
Monday, December 17
Holiday Break
n/a
We are grateful to each of our 2006 facilitators and panelists for their participation and support and proudly acknowledge them below.
Date
Title
Facilitator
Monday, September 18
Life Sciences Entrepreneurs' Forum, Theme: Bringing the Product to Market
Melinda Richter, San Jose Bioscience Center Michael Shuster, Fenwick & West
Monday, October 16
Life Sciences Entrepreneurs' Forum Theme: Preparing for Outside Investors
Ken Macrae Geetha Rao Sergio Garcia
Monday, November 20
Life Sciences Entrepreneurs' Forum Theme: Building an A+ Life Science Management Team
Roy Fiebieger Tom Afzal, CEO of SpinalKinetics Andrew Farquharson, InCube Mike Hall, Latham & Watkins
Monday, December 18
Life Sciences Entrepreneurs' Forum: Holiday Break
n/a
FountainBlue's life sciences forums set themselves apart in that they address and connect multidisciplinary life sciences executives and investors.This is inclusive of, but not limited to medical devices, BioPharma, and emerging technologies such as wireless and nanotechnology applications in healthcare.We connect the companies' executives of various sizes that have different capabilities i.e. discovery vs. development to enhance relationships and foster productive discussions to promote common goals and expectations.
Sherri Dohemann, FountainBlues Chair and Director of Outreach for the Life Science Community
Join the FountainBlue community by completing the form below.
If youre already a member, feel free to log in below.
